WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Stock Ownership - Who owns Actuate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Actuate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel M. SchmittPresident CEO and Director2026-02-13121,874$4.33
$527.71kSell
Todd S. ThomsonDirector2026-01-05280,000$5.80
$1.62MSell
Bios Equity Cof LPDirector2025-06-2771,428$7.00
$500.00kBuy
Aaron Gl FletcherDirector2025-06-2771,428$7.00
$500.00kBuy
Leslie W. KreisDirector2025-06-2771,428$7.00
$500.00kBuy

1 of 1

ACTU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACTU insiders and whales buy or sell their stock.

ACTU Shareholders

What type of owners hold Actuate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis43.87%10,196,456$28.24MInsider
Aaron Gl Fletcher43.87%10,196,456$28.24MInsider
Bios Equity Cof LP43.87%10,196,456$28.24MInsider
Bios Capital Management LP43.24%10,049,996$27.84MInstitution
Todd S. Thomson10.13%2,354,344$6.52MInsider
Voss Capital LP5.59%1,300,000$3.60MInstitution
Daniel M. Schmitt3.36%780,921$2.16MInsider
Vanguard Group Inc2.28%529,111$1.47MInstitution
Blackrock Inc1.86%432,041$1.20MInstitution
Geode Capital Management LLC0.89%207,744$575.45kInstitution

1 of 3

ACTU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACTU27.99%72.01%Net SellingNet Selling
COEP4.92%95.08%Net BuyingNet Buying
IFRX28.59%6.41%
EXOZ0.46%99.54%Net Buying
FRMM22.60%58.94%Net Buying
View Top Biotech Stocks

Actuate Therapeutics Stock Ownership FAQ

Who owns Actuate Therapeutics?

Actuate Therapeutics (NASDAQ: ACTU) is owned by 56.40% institutional shareholders, 145.09% Actuate Therapeutics insiders, and 0.00% retail investors. Leslie W. Kreis is the largest individual Actuate Therapeutics shareholder, owning 10.20M shares representing 43.87% of the company. Leslie W. Kreis's Actuate Therapeutics shares are currently valued at $25.70M.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.